Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Adient's revenue declined 1% year-over-year, from $14.7B to $14.5B. This contraction results in a growth score of 26/100.
Adient has a moderate D/E ratio of 1.35. This balance of debt and equity financing earns a leverage score of 61/100.
Adient's current ratio of 1.12 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 25/100, which could limit financial flexibility.
Adient's free cash flow margin of 1.4% results in a low score of 7/100. Capital expenditures of $245.0M absorb a large share of operating cash flow.
Adient passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Adient generates $-1.60 in operating cash flow ($449.0M OCF vs -$281.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
This page shows Adient (ADNT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Adient generated $14.5B in revenue in fiscal year 2025. This represents a decrease of 1.0% from the prior year.
Adient generated $204.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 26.4% from the prior year.
Adient reported -$281.0M in net income in fiscal year 2025. This represents a decrease of 1661.1% from the prior year.
Adient earned $-3.39 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1795.0% from the prior year.
Adient held $958.0M in cash against $2.4B in long-term debt as of fiscal year 2025.
Adient had 79M shares outstanding in fiscal year 2025. This represents a decrease of 6.7% from the prior year.
Adient's gross margin was 6.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Adient's net profit margin was -1.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.1 percentage points from the prior year.
Adient invested $387.0M in research and development in fiscal year 2025. This represents an increase of 4.0% from the prior year.
Adient spent $125.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 54.5% from the prior year.
Adient invested $245.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 7.9% from the prior year.
ADNT Income Statement
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B-2.6% | $3.7B+3.6% | $3.6B+3.3% | $3.5B-5.9% | $3.7B-0.9% | $3.8B+2.5% | $3.7B-9.7% | $4.1B |
| Cost of Revenue | $3.4B-2.2% | $3.5B+4.6% | $3.4B+2.2% | $3.3B-6.6% | $3.5B-0.3% | $3.5B+3.1% | $3.4B-9.0% | $3.8B |
| Gross Profit | $217.0M-8.4% | $237.0M-9.2% | $261.0M+20.8% | $216.0M+4.3% | $207.0M-10.0% | $230.0M-6.5% | $246.0M-18.5% | $302.0M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $130.0M+0.8% | $129.0M-10.4% | $144.0M+15.2% | $125.0M+3.3% | $121.0M+5.2% | $115.0M-21.8% | $147.0M-0.7% | $148.0M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $53.0M+203.9% | -$51.0M-6.3% | -$48.0M-192.3% | $52.0M+208.3% | -$48.0M-2.1% | -$47.0M-178.3% | $60.0M+222.4% | -$49.0M |
| Income Tax | $42.0M+500.0% | $7.0M-85.4% | $48.0M+118.2% | $22.0M-45.0% | $40.0M+400.0% | $8.0M-60.0% | $20.0M-28.6% | $28.0M |
| Net Income | -$22.0M-161.1% | $36.0M+110.7% | -$335.0M | $0+100.0% | -$11.0M+84.3% | -$70.0M-450.0% | $20.0M-72.6% | $73.0M |
| EPS (Diluted) | $-0.28-165.1% | $0.43+110.8% | $-3.99 | $0.00+100.0% | $-0.12+84.4% | $-0.77-466.7% | $0.21-72.7% | $0.77 |
ADNT Balance Sheet
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8B-0.7% | $8.8B+2.9% | $8.6B+0.7% | $8.5B-8.7% | $9.4B+0.8% | $9.3B-0.2% | $9.3B-1.3% | $9.4B |
| Current Assets | $3.9B-2.6% | $4.0B+3.3% | $3.9B+10.6% | $3.5B-13.9% | $4.1B-0.9% | $4.1B+1.3% | $4.1B-5.6% | $4.3B |
| Cash & Equivalents | $855.0M-0.6% | $860.0M+14.1% | $754.0M-12.3% | $860.0M-9.0% | $945.0M+4.4% | $905.0M-8.6% | $990.0M-10.8% | $1.1B |
| Inventory | $760.0M+4.7% | $726.0M+1.0% | $719.0M-0.3% | $721.0M-4.9% | $758.0M-4.2% | $791.0M-5.0% | $833.0M-1.0% | $841.0M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $1.8B+0.4% | $1.8B+1.1% | $1.8B-14.7% | $2.1B-3.4% | $2.2B+3.1% | $2.1B-1.8% | $2.1B+2.1% | $2.1B |
| Total Liabilities | $7.0B-0.2% | $7.1B+1.6% | $6.9B+4.2% | $6.7B-7.8% | $7.2B+0.2% | $7.2B+2.7% | $7.0B-2.6% | $7.2B |
| Current Liabilities | $3.6B-0.2% | $3.6B+2.5% | $3.5B+7.9% | $3.3B-11.6% | $3.7B+0.5% | $3.7B+3.1% | $3.5B-5.1% | $3.7B |
| Long-Term Debt | $2.4B-0.2% | $2.4B0.0% | $2.4B-0.3% | $2.4B-0.1% | $2.4B-0.2% | $2.4B-0.1% | $2.4B+0.1% | $2.4B |
| Total Equity | $1.7B-2.8% | $1.8B+8.1% | $1.7B-12.0% | $1.9B-12.0% | $2.1B+2.8% | $2.1B-9.2% | $2.3B+2.6% | $2.2B |
| Retained Earnings | -$1.2B-0.3% | -$1.2B+3.0% | -$1.2B-37.9% | -$885.0M0.0% | -$885.0M+7.1% | -$953.0M-7.9% | -$883.0M+2.2% | -$903.0M |
ADNT Cash Flow Statement
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $80.0M-53.5% | $172.0M+482.2% | -$45.0M-141.3% | $109.0M-58.6% | $263.0M+224.7% | $81.0M+97.6% | $41.0M-86.1% | $294.0M |
| Capital Expenditures | $65.0M+14.0% | $57.0M+26.7% | $45.0M-29.7% | $64.0M-11.1% | $72.0M+4.3% | $69.0M+25.5% | $55.0M-26.7% | $75.0M |
| Free Cash Flow | $15.0M-87.0% | $115.0M+227.8% | -$90.0M-300.0% | $45.0M-76.4% | $191.0M+1491.7% | $12.0M+185.7% | -$14.0M-106.4% | $219.0M |
| Investing Cash Flow | -$68.0M-38.8% | -$49.0M-11.4% | -$44.0M-29.4% | -$34.0M+51.4% | -$70.0M-1.4% | -$69.0M-56.8% | -$44.0M+32.3% | -$65.0M |
| Financing Cash Flow | -$114.0M-81.0% | -$63.0M-34.0% | -$47.0M+53.9% | -$102.0M+46.0% | -$189.0M-186.4% | -$66.0M+57.4% | -$155.0M-1450.0% | -$10.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $25.0M-50.0% | $50.0M | $0-100.0% | $25.0M-50.0% | $50.0M-66.7% | $150.0M+50.0% | $100.0M | $0 |
ADNT Financial Ratios
| Metric | Q1'25 | Q3'25 | Q2'25 | Q1'24 | Q3'24 | Q2'24 | Q1'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 5.9%-0.4pp | 6.3%-0.9pp | 7.2%+1.1pp | 6.2%+0.6pp | 5.6%-0.6pp | 6.1%-0.6pp | 6.7%-0.7pp | 7.4% |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -0.6%-1.6pp | 1.0%+10.2pp | -9.3%-9.3pp | 0.0%+0.3pp | -0.3%+1.6pp | -1.9%-2.4pp | 0.5%-1.3pp | 1.8% |
| Return on Equity | N/A | 2.0% | N/A | N/A | N/A | N/A | 0.9%-2.5pp | 3.4% |
| Return on Assets | -0.3%-0.7pp | 0.4%+4.3pp | -3.9%-3.9pp | 0.0%+0.1pp | -0.1%+0.6pp | -0.8%-1.0pp | 0.2%-0.5pp | 0.8% |
| Current Ratio | 1.09-0.0 | 1.120.0 | 1.11+0.0 | 1.08-0.0 | 1.11-0.0 | 1.13-0.0 | 1.150.0 | 1.15 |
| Debt-to-Equity | 1.37+0.0 | 1.34-0.1 | 1.44+0.2 | 1.28+0.2 | 1.12-0.0 | 1.16+0.1 | 1.05-0.0 | 1.08 |
| FCF Margin | 0.4%-2.7pp | 3.1%+5.6pp | -2.5%-3.8pp | 1.3%-1.1pp | 2.4%+2.0pp | 0.3%+0.7pp | -0.4%-3.9pp | 3.5% |
Similar Companies
Frequently Asked Questions
What is Adient's annual revenue?
Adient (ADNT) reported $14.5B in total revenue for fiscal year 2025. This represents a -1.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Adient's revenue growing?
Adient (ADNT) revenue declined by 1% year-over-year, from $14.7B to $14.5B in fiscal year 2025.
Is Adient profitable?
No, Adient (ADNT) reported a net income of -$281.0M in fiscal year 2025, with a net profit margin of -1.9%.
What is Adient's earnings per share (EPS)?
Adient (ADNT) reported diluted earnings per share of $-3.39 for fiscal year 2025. This represents a -1795.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does Adient have?
As of fiscal year 2025, Adient (ADNT) had $958.0M in cash and equivalents against $2.4B in long-term debt.
What is Adient's gross margin?
Adient (ADNT) had a gross margin of 6.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Adient's net profit margin?
Adient (ADNT) had a net profit margin of -1.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Adient's free cash flow?
Adient (ADNT) generated $204.0M in free cash flow during fiscal year 2025. This represents a -26.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Adient's operating cash flow?
Adient (ADNT) generated $449.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Adient's total assets?
Adient (ADNT) had $9.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Adient's capital expenditures?
Adient (ADNT) invested $245.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Adient spend on research and development?
Adient (ADNT) invested $387.0M in research and development during fiscal year 2025.
Does Adient buy back shares?
Yes, Adient (ADNT) spent $125.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
How many shares does Adient have outstanding?
Adient (ADNT) had 79M shares outstanding as of fiscal year 2025.
What is Adient's current ratio?
Adient (ADNT) had a current ratio of 1.12 as of fiscal year 2025, which is considered adequate.
What is Adient's debt-to-equity ratio?
Adient (ADNT) had a debt-to-equity ratio of 1.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Adient's return on assets (ROA)?
Adient (ADNT) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Adient's Piotroski F-Score?
Adient (ADNT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Adient's earnings high quality?
Adient (ADNT) has an earnings quality ratio of -1.60x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Adient?
Adient (ADNT) scores 30 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.